Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Search content at Albert Einstein College of Medicine
Home
Faculty
Departments
Grants
Publications
Prizes
Focal Ablation for Prostate Cancer
Julio M. Pow-Sang
, Einar F. Sverrisson
,
Oscar M. Valderrama
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Focal Ablation for Prostate Cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Prostate Cancer
100%
Focal Ablation
100%
Tumor
66%
United States
66%
Quality of Life
66%
Indolent Cancer
66%
Treatment Options
33%
Ablation Therapy
33%
Radiation Therapy
33%
Cancer Mortality
33%
Cancer Causes
33%
Active Surveillance
33%
Commercially Available
33%
Erectile Dysfunction
33%
Prostate
33%
Cancer Progression
33%
Radical Prostatectomy
33%
Life Expectancy
33%
Incontinence
33%
Energy Sources
33%
Clinical Test
33%
Cryoablation
33%
Photodynamic Therapy
33%
Intermediate-risk Prostate Cancer
33%
Laser Ablation
33%
Overtreatment
33%
High-intensity Focused Ultrasound
33%
Cryosurgery
33%
Low-risk Prostate Cancer
33%
Medicine and Dentistry
Prostate Cancer
100%
Malignant Neoplasm
50%
Quality of Life
50%
Cryosurgery
50%
Neoplasm
25%
Ablation Therapy
25%
Cancer Mortality
25%
Cancer Growth
25%
Erectile Dysfunction
25%
Prostatectomy
25%
Life Expectancy
25%
Incontinence
25%
Laser Surgery
25%
Cryoablation
25%
Overdiagnosis
25%
High-Intensity Focused Ultrasound
25%
Photochemotherapy
25%
Radiation Therapy
25%
Tumor
25%
Treatment Option
25%
Nursing and Health Professions
Prostate Cancer
100%
Malignant Neoplasm
50%
Cryosurgery
50%
Quality of Life
50%
Neoplasm
25%
Cancer Mortality
25%
Life Expectancy
25%
Erectile Dysfunction
25%
Ablation Therapy
25%
Incontinence
25%
Prostatectomy
25%
High Intensity Focused Ultrasound
25%
Cancer Growth
25%
Cryoablation
25%
Laser Surgery
25%
Radiotherapy
25%
Photochemotherapy
25%